Drug pricing watchdog says thereâs âinsufficientâ evidence that Biogenâs Alzheimerâs medicine would help patients
In a draft report, Boston-based ICER cites conflicting data from two trials. The Cambridge biotech says it âdoes not accurately reflect the possible holistic valueâ of the experimental treatment.
By Jonathan Saltzman Globe Staff,Updated May 5, 2021, 5:01 p.m.
Email to a Friend
Biogen s headquarters in Cambridge.John Tlumacki/Globe Staff/file
Biogenâs closely watched experimental medicine for Alzheimerâs disease has generated âinsufficientâ evidence to conclude that it would help patients, according to a withering assessment from an influential drug-pricing watchdog group that comes four weeks before regulators decide whether to approve it.
Share this article
Share this article
ZUG, Switzerland, May 4, 2021 /PRNewswire/ Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announces that it has entered into a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) for the protocol titled, A Randomized, Placebo-Controlled, Double-Blind Phase 3 Trial Comparing, Relative to Placebo, the Effect of Isoquercetin on Thromboembolic Events in Patients with Metastatic Pancreatic Cancer (CATIQ P3).
Isoquercetin, the Company s lead product candidate, employs a novel pathway that is based on a new mechanism of action to prevent or reverse thrombus formation with a profile that potentially conveys substantially lowered bleeding risk compared to current standard of care. These mechanisms are related to key thrombotic pathways, including the inhibition of soluble P-selectin, which is known to help prevent or reduce thro
In Longwood Medical Area, jobs were being added about twice as fast as in the state overall
A study says employment in Bostonâs medical hub grew nearly 30% from 2008 to 2019
By Jon Chesto Globe Staff,Updated May 3, 2021, 3:51 p.m.
Email to a Friend
Medical employees and others make their way across Brookline Avenue. A study of Longwood Medical Area s growth suggests transit improvements might benefit the area.David L. Ryan/Globe Staff
Longwood Medical Area has come a long way from the days when Boston Childrenâs Hospital set up shop on Huntington Avenue with 60 beds and a herd of cows to provide kids with tuberculosis-free milk.
ABC News
Turn on desktop notifications for breaking stories about interest?
OffOn Absolutely go and get that second dose.
• 5 min read
Catch up on the developing stories making headlines.Joseph Prezioso/AFP via Getty Images, FILE
About 5 million Americans missed receiving their second dose of Pfizer or Moderna COVID-19 vaccine, according to Centers for Disease Control and Prevention data released on Sunday.
But with some upcoming activities traveling and returning to school among them possibly requiring proof of a full vaccination two doses of Pfizer or Moderna vaccine or a single dose of Johnson & Johnson experts told ABC News it s still not too late for those who still need a second shot.